2.12

1.85% -0.04

Xbiotech Inc (XBIT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$2.16

Aprire:

$2.16

Volume 24 ore:

68,197

Relative Volume:

1.16

Capitalizzazione di mercato:

$64.63M

Reddito:

$300.00K

Utile/perdita netta:

$-40.16M

Rapporto P/E:

-1.6092

EPS:

-1.3174

Flusso di cassa netto:

$-42.36M

1 W Prestazione:

-7.42%

1M Prestazione:

-1.40%

6M Prestazione:

-12.76%

1 anno Prestazione:

-14.86%

Intervallo 1D:

$2.10

$2.22

Intervallo di 1 settimana:

$2.10

$2.33

Portata 52W:

$2.09

$3.44

Xbiotech Inc Stock (XBIT) Company Profile

Nome

Xbiotech Inc

Settore

Healthcare (1052)

Industria

Biotechnology (594)

Telefono

512-386-2900

Indirizzo

5217 WINNEBAGO LANE, AUSTIN, TX

Dipendente

Cinguettio

@xbiotech_usa

Prossima data di guadagno

2026-11-11

Ultimi documenti SEC

XBIT's Discussions on Twitter

Compare XBIT vs VRTX, MRNA, REGN, ARGX, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
XBIT Xbiotech Inc	2.12	64.63M	300.00K	-40.16M	-42.36M	-1.3174
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2019-06-14	Iniziato	Piper Jaffray	Overweight
2017-04-21	Downgrade	Noble Financial	Buy → Hold
2016-06-28	Reiterato	Noble Financial	Buy

Xbiotech Inc Borsa (XBIT) Ultime notizie

Oct 08, 2026

$17.3M in severance is part of a former CEO's 2025 compensation at XBiotech (XBIT). - Stock Titan

Oct 02, 2026

Sep 18, 2026

Xbiotech Stock Price Forecast. Should You Buy XBIT? - StockInvest.us

Sep 18, 2026

Sep 03, 2026

XBiotech (NASDAQ:XBIT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat

Sep 03, 2026

Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Supply Zone - vinanet.vn

Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Sector ETF Flow - careplusvn.com

Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Island Reversal - dars.gov.et

Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08OBV Trend Line - dars.gov.et

Sep 01, 2026

Aug 26, 2026

XBiotech (NASDAQ:XBIT) Share Price Passes Above 50 Day Moving AverageHere's What Happened - MarketBeat

Aug 26, 2026

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - vinanet.vn

Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseEarly Entry Signals - vinanet.vn

Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseLinear Regression - dars.gov.et

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseRevenue Growth Outlook - dars.gov.et

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - siam.in

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - dars.gov.et

Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseMomentum ETF - careplusvn.com

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseProfitability Analysis - dars.gov.et

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseEarnings Call Q&A - www.dars.gov.et

Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseInitial Balance - dars.gov.et

Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseBull Flag - dars.gov.et

Aug 24, 2026

Aug 13, 2026

XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS - MarketBeat

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - marketscreener.com

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - AOL.com

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - Enidnews.com

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - KTVB

Aug 13, 2026

XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026 - Stock Titan

Aug 13, 2026

XBiotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - Barchart.com

Aug 13, 2026

XBiotech (XBIT) Earnings Date and Reports 2026 $XBIT - MarketBeat

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - Yahoo Finance

Aug 13, 2026

Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceOverbought Signal Alerts - careplusvn.com

Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceRip Sell Trade - dars.gov.et

Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceActive ETF Flow - dars.gov.et

Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceJelly Roll Trade - dars.gov.et

Aug 11, 2026

Aug 10, 2026